MedPath

SWAMI RAMA HIMALAYAN UNIVERSITY

🇮🇳India
Ownership
-
Established
2012-01-01
Employees
-
Market Cap
-
Website
http://srhu.edu.in

Clinical Trials

15

Active:0
Completed:4

Trial Phases

3 Phases

Phase 2:1
Phase 4:2
Not Applicable:5

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials

Not Applicable
5 (55.6%)
Phase 4
2 (22.2%)
Phase 2
1 (11.1%)
phase_2_3
1 (11.1%)

Chemotherapy Induced Neuropathy in Cancer Patients

Recruiting
Conditions
Chemotherapy-induced Peripheral Neuropathy
Interventions
Drug: Cisplatin, Carboplatin, Paclitaxel, Docetaxel
First Posted Date
2024-07-08
Last Posted Date
2024-07-08
Lead Sponsor
Swami Rama Himalayan University
Target Recruit Count
124
Registration Number
NCT06491082
Locations
🇮🇳

Himalayan Hospital(Cancer Research Institute), Himalayan Institute of Medical Sciences, Dehradun, India

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.